Cirrhosis News and Research

Latest Cirrhosis News and Research

Widespread HCV testing and treatment strategy in U.S. prisons improves outcomes

At current drug prices, testing all persons entering prison for Hepatitis C, treating those who have at least 12 months remaining in their sentence, and linking individuals with less than 12 months in their sentence to care upon their release would result in improved health outcomes.

22 May 2019

Walking and muscle-strengthening activities associated with reduced risk of cirrhosis-related death

Physical activity, including walking and muscle-strengthening activities, were associated with significantly reduced risk of cirrhosis-related death, according to research presented at Digestive Disease Week (DDW) 2019.

20 May 2019

Study: People with type 2 diabetes are at particular risk of deadly liver disease

Many patients with potentially deadly liver cirrhosis and liver cancer are being diagnosed at late advanced stages of disease, according to a study led by Queen Mary University of London and the University of Glasgow.

20 May 2019

Researchers describe the impact of chronic hepatitis D on parts of the immune system

Approximately one out of every ten people with hepatitis B are coinfected with hepatitis D, which is among the most serious liver conditions.

15 May 2019

New findings could facilitate the development of hepatitis C mouse model

Small differences in a liver cell protein have significant impacts on hepatitis C virus replication in mice and humans, findings that could facilitate the development of a mouse model of the infection. The report, led by researchers at Princeton University, was published today in the journal eLife.

12 May 2019

The homeless are dying in record numbers on the streets of L.A.

A record number of homeless people — 918 last year alone — are dying across Los Angeles County, on bus benches, hillsides, railroad tracks and sidewalks.

24 Apr 2019

Mediterranean diet protects against overeating and obesity

Eat as much as you want and not gain weight? Sounds too good to be true.

23 Apr 2019

Liver illness strikes Latino children like a ‘silent tsunami’

Saira Diaz uses her fingers to count the establishments selling fast food and sweets near the South Los Angeles home she shares with her parents and 13-year-old son. “There’s one, two, three, four, five fast-food restaurants,” she says. “And a little mom and pop store that sells snacks and sodas and candy.”

19 Apr 2019

Indicators of despair rising among Americans entering midlife

Indicators of despair--depression, suicidal ideation, drug use and alcohol abuse--are rising among Americans in their late 30s and early 40s across most demographic groups, according to new research led by Lauren Gaydosh, assistant professor of Medicine, Health and Society and Public Policy Studies at Vanderbilt University.

16 Apr 2019

Aldo-keto reductase family 1 member B10 enzyme found in advanced liver diseases

Nonalcoholic steatohepatitis is associated with liver inflammation in patients with nonalcoholic fatty liver disease, and it can progress to liver fibrosis at an advanced stage, and also to hepatocellular carcinoma and portal hypertension.

12 Apr 2019

Researchers discover pathway contributing to fatty liver disease

Researchers from Karolinska Institutet have found a protein that is a critical regulator in the development of fatty liver disease in mice, according to a study published in the journal Nature Communications.

11 Apr 2019

Hepatitis C infections could be reduced by stepping up efforts to prevent transmission in people who inject drugs

Stepping up efforts to prevent transmission of hepatitis C among people who inject drugs, could reduce future infections by 43 per cent globally, according to a study by researchers at the University of Bristol published in the Lancet Gastroenterology and Hepatology today [Tuesday 9 April 2019].

10 Apr 2019

TGen review associates a gene with hepatocellular carcinoma

Hepatocellular carcinoma is a long medical name for the most common form of liver cancer, a malignancy whose incidence has nearly doubled over the past decade, making it the fastest growing type of cancer in the U.S., and the third-leading cause of cancer-related death worldwide.

9 Apr 2019

Study offers new hope for patients with decompensated cirrhosis

Decompensated cirrhosis is a chronic disease linked to numerous complications in its final stage. Professor Jonel Trebicka from Goethe University was involved in carrying out a pilot study demonstrating that the long-term administration of albumin in high doses stabilizes the circulatory function of these patients and protects them from sepsis.

4 Apr 2019

Study uncovers genetic variant associated with liver fibrosis in chronic hepatitis C patients

A new study from The Westmead Institute for Medical Research has identified a genetic variant associated with liver fibrosis (scarring) in chronic hepatitis C patients. This finding is a step toward reducing the number of patients requiring liver transplants.

3 Apr 2019

European surveillance data shows slight decrease in newly reported hepatitis C cases

European surveillance data show a 10% decrease in newly reported hepatitis C cases between 2016 and 2017. However, with more than 31 000 recorded cases in 2017, diagnoses remain at a high level in the European Union and European Economic Area.

2 Apr 2019

WHO guidelines for chronic hepatitis B fail to detect half of the patients in Ethiopia needing treatment

Current World Health Organization (WHO) guidelines for chronic hepatitis B (CHB) fail to detect half of the patients in need of treatment in Ethiopia, report scientists in the Journal of Hepatology, published by Elsevier.

29 Mar 2019

Mayo Clinic study identifies potential new drug therapy for liver diseases

Drug therapy may effectively treat a potentially life-threatening condition associated with cirrhosis and other chronic liver diseases, according to a new study by Mayo Clinic researchers.

22 Mar 2019

Researchers identify first genetic defect linked to biliary atresia

A nationwide consortium of researchers has identified the first genetic defect linked to biliary atresia, a mysterious liver disease that is the leading cause for liver transplantation in children.

5 Mar 2019

Discovery paves the way for simple blood test to detect early stages of NAFLD

One in four people in Western and Asian societies develop a build-up of fat in the liver as a result of an unhealthy diet. This disease - referred to as non-alcoholic fatty liver disease (NAFLD) - causes no symptoms initially but can develop into end-stage liver cirrhosis with limited treatment options.

1 Mar 2019